Recent progress in vaccines against fungal diseases.

Current Opinion in Microbiology
Antonio Cassone, A Casadevall

Abstract

Diseases caused by fungi are increasingly impacting the health of the human population and now account for a large fraction of infectious disease complications in individuals with impaired immunity or breached tissue defenses. Antifungal therapy is often of limited effectiveness in these patients, resulting into treatment failures, chronic infections and unacceptable rates of mortality, morbidity and their associated costs. Consequently there is a real medical need for new treatments and preventive measures to combat fungal diseases and, toward this goal, safe and efficacious vaccines would constitute major progress. After decades of complacency and neglect of this critically important field of research, remarkable progress has been made in recent years. A number of highly immunogenic and protective vaccine formulations in preclinical setting have been developed, and at least two have undergone Phase 1 clinical trials as preventive and/or therapeutic tools against candidiasis.

References

Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A Stevens
Sep 9, 2005·The Journal of Experimental Medicine·Antonella TorosantucciAntonio Cassone
May 16, 2006·FEMS Yeast Research·Kausik Datta, Liise-anne Pirofski
Jun 17, 2006·The Journal of Infectious Diseases·Brad J SpellbergJohn E Edwards
Dec 13, 2006·Nature Reviews. Microbiology·Jim E CutlerBruce S Klein
Sep 28, 2007·European Journal of Immunology·Teresa ZelanteLuigina Romani
Jan 29, 2008·The Lancet Infectious Diseases·Antonio Cassone
Feb 20, 2008·PLoS Pathogens·Andrew Y KohGerald B Pier
Jan 23, 2009·FEMS Immunology and Medical Microbiology·Lin LinBrad Spellberg
Jun 17, 2009·The Journal of Infectious Diseases·Krishanthi SubramaniamLiise-Anne Pirofski
Dec 31, 2009·The Journal of Infectious Diseases·Beverlie BaquirBrad Spellberg
Jan 22, 2010·Critical Reviews in Microbiology·Michael A Pfaller, Daniel J Diekema
Jan 26, 2010·Vaccine·Carla BromuroAntonio Cassone
Mar 26, 2010·The Journal of Clinical Investigation·Erin E McClellandArturo Casadevall
Aug 21, 2010·Nature Reviews. Drug Discovery·Luis Ostrosky-ZeichnerJohn H Rex
Feb 11, 2011·Current Infectious Disease Reports·Paul L Fidel, Jim E Cutler
Mar 12, 2011·Nature Reviews. Immunology·Luigina Romani
Mar 23, 2011·Infection and Immunity·Diana Diaz-ArevaloMarkus Kalkum
Jun 15, 2011·Lancet·E Richard Moxon, Claire-Anne Siegrist
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Anja SeubertEnnio De Gregorio
Aug 10, 2011·Journal of Medical Microbiology·Min LiuDavid A Stevens
Aug 13, 2011·Clinical and Vaccine Immunology : CVI·Hong Xin, Jim E Cutler
Aug 31, 2011·F1000 Medicine Reports·Brad Spellberg
Nov 5, 2011·Nature Reviews. Immunology·Rino RappuoliEnnio De Gregorio

❮ Previous
Next ❯

Citations

Mar 4, 2014·PLoS Pathogens·Vanessa EspinosaAmariliz Rivera
Apr 16, 2013·Current Fungal Infection Reports·Garry T ColeChiung-Yu Hung
Oct 17, 2015·Pathogens·Flavia De BernardisSandro Norelli
Sep 15, 2016·ACS Infectious Diseases·Guochao LiaoZhongwu Guo
Aug 27, 2014·Microbiology and Immunology·Lucia PaulovičováSlavomír Bystrický
Sep 4, 2015·Hand : Official Journal of the American Association for Hand Surgery·Jens U BerliRyan D Katz
Jul 30, 2014·Biochemical and Biophysical Research Communications·Shulong YangYurong Zeng
Apr 15, 2016·Virulence·Yulin QinYongbing Cao
Jan 7, 2015·Virulence·Xiao-juan WangYuan-ying Jiang
Mar 19, 2013·Cell Host & Microbe·Jacqueline M Achkar, Arturo Casadevall
Nov 26, 2015·Memórias do Instituto Oswaldo Cruz·Natasha P Medici, Maurizio Del Poeta
Nov 20, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Preeyam Patel, John F Kearney
Mar 15, 2018·Medical Mycology·Flavia De BernardisStavroula Antonopoulou
Aug 11, 2015·European Journal of Organic Chemistry·Guochao LiaoZhongwu Guo
Nov 16, 2013·Nature Reviews. Microbiology·Antonio Cassone
Mar 4, 2020·Journal of Fungi·Camila BonicheCarlos Pelleschi Taborda
Sep 16, 2017·The Journal of Infectious Diseases·Matthew W McCarthyThomas J Walsh
May 1, 2020·Frontiers in Chemistry·Shuyao Lang, Xuefei Huang
Jun 25, 2014·Expert Review of Vaccines·Maria Dolores MoraguesGuillermo Quindos
Jul 30, 2020·Journal of Fungi·Leandro B R Da SilvaJoshua D Nosanchuk
Jan 24, 2018·Frontiers in Immunology·Pappanaicken R KumaresanDimitrios P Kontoyiannis
Dec 19, 2018·Journal of Fungi·Chris D LauruschkatJuergen Loeffler
Oct 6, 2020·Frontiers in Cellular and Infection Microbiology·Brenda KischkelCarlos P Taborda
Jan 13, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Trenton W J GarnerJaime Bosch
Feb 3, 2021·Mycoses·Alex FarrWerner Mendling
Nov 7, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sanam NamiHamid Morovati
Mar 23, 2021·British Journal of Biomedical Science·H T PattisonJ E Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Science
Gordon D BrownStuart M Levitz
The New England Journal of Medicine
April C PettitMeredith E Pugh
Current Opinion in Microbiology
Mihai G Netea, Gordon D Brown
© 2021 Meta ULC. All rights reserved